Phase I study of the heparanase inhibitor roneparstat: An innovative approach for multiple myeloma therapy

Monica Galli; Manik Chatterjee; Mariella Grasso; Giorgina Specchia; Hila Magen; Hermann Einsele; Ivana Celeghini; Paola Barbieri; David Paoletti; Silvia Pace; Ralph D. Sanderson; Alessandro Rambaldi; Arnon Nagler

doi:10.3324/haematol.2017.182865

Phase I study of the heparanase inhibitor roneparstat: An innovative approach for multiple myeloma therapy

Monica Galli^*, Manik Chatterjee, Mariella Grasso, Giorgina Specchia, Hila Magen, Hermann Einsele, Ivana Celeghini, Paola Barbieri, David Paoletti, Silvia Pace, Ralph D. Sanderson, Alessandro Rambaldi, Arnon Nagler

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

94 Scopus citations

Original language	English
Pages (from-to)	e469-e472
Journal	Haematologica
Volume	103
Issue number	10
DOIs	https://doi.org/10.3324/haematol.2017.182865
State	Published - 30 Sep 2018
Externally published	Yes

Funding

Funders	Funder number
National Cancer Institute	R01CA211752

Access to Document

10.3324/haematol.2017.182865

Cite this

Galli, M., Chatterjee, M., Grasso, M., Specchia, G., Magen, H., Einsele, H., Celeghini, I., Barbieri, P., Paoletti, D., Pace, S., Sanderson, R. D., Rambaldi, A., & Nagler, A. (2018). Phase I study of the heparanase inhibitor roneparstat: An innovative approach for multiple myeloma therapy. Haematologica, 103(10), e469-e472. https://doi.org/10.3324/haematol.2017.182865

@article{027e68ed5f0c4e23931ee4509ecf5d32,

title = "Phase I study of the heparanase inhibitor roneparstat: An innovative approach for multiple myeloma therapy",

author = "Monica Galli and Manik Chatterjee and Mariella Grasso and Giorgina Specchia and Hila Magen and Hermann Einsele and Ivana Celeghini and Paola Barbieri and David Paoletti and Silvia Pace and Sanderson, {Ralph D.} and Alessandro Rambaldi and Arnon Nagler",

year = "2018",

month = sep,

day = "30",

doi = "10.3324/haematol.2017.182865",

language = "אנגלית",

volume = "103",

pages = "e469--e472",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "10",

}

TY - JOUR

T1 - Phase I study of the heparanase inhibitor roneparstat

T2 - An innovative approach for multiple myeloma therapy

AU - Galli, Monica

AU - Chatterjee, Manik

AU - Grasso, Mariella

AU - Specchia, Giorgina

AU - Magen, Hila

AU - Einsele, Hermann

AU - Celeghini, Ivana

AU - Barbieri, Paola

AU - Paoletti, David

AU - Pace, Silvia

AU - Sanderson, Ralph D.

AU - Rambaldi, Alessandro

AU - Nagler, Arnon

PY - 2018/9/30

Y1 - 2018/9/30

UR - http://www.scopus.com/inward/record.url?scp=85053128287&partnerID=8YFLogxK

U2 - 10.3324/haematol.2017.182865

DO - 10.3324/haematol.2017.182865

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 29700168

AN - SCOPUS:85053128287

SN - 0390-6078

VL - 103

SP - e469-e472

JO - Haematologica

JF - Haematologica

IS - 10

ER -

Phase I study of the heparanase inhibitor roneparstat: An innovative approach for multiple myeloma therapy

Funding

Access to Document

Other files and links

Cite this